Hacking | What’s in the Blue Box? | S46-E1

No extreme weather phenomenon fascinates us more than tornadoes. For most of human history, very little was known about how these graceful yet violent columns of swirling air formed or behaved. Then, in the 1950s, a teenager from North Dakota began chasing them, and a scientist f ...  Show more

No extreme weather phenomenon fascinates us more than tornadoes. For most of human history, very little was known about how these graceful yet violent columns of swirling air formed or behaved. Then, in the 1950s, a teenager from North Dakota began chasing them, and a scientis ...

The Food and Drug Administration has granted priority review to suzetrigine, a novel painkiller. It’s part of a new class of medications that could provide relief to those with chronic pain. The drugs target sodium channels on nerve cells, stopping pain signaling at the periphery ...  Show more

Imagine living with excruciating pain that prevents you from walking or doing the things most of us take for granted. We all experience pain, and 50 million people cope with chronic, debilitating pain. The market for pain therapies is estimated at $74 billion. And yet, investment ...  Show more

A deep dive into the beginnings of the opioid epidemic, this episodes serves to expose Purdue Pharma’s deceitful claims, which allowed prescriptions of Oxycontin to go out of control. With a look at the ramifications on ethical, legal, and socio-economical levels, this episode re ...  Show more

In 1960, FDA scientist Frances Oldham Kelsey is tasked with approving an application for a mild sedative to be sold in America. The drug is popular across Europe and is touted to be free of side effects, so this should be a routine job. But something doesn't sit right with France ...  Show more